Author:
Kirrane Barbara M.,Duthie Elizabeth A.,Nelson Lewis S.
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference12 articles.
1. US Food and Drug Administration, [web page on the Internet]. Important safety information on interference with blood glucose measurement following use of parenteral maltose/parenteral galactose/oral-xylose-containing products [cited 2007 November 19]. Available at: http://www.fda.gov/ cber/safety/maltose 110405.htm
2. Ghys T, Goedhuys W, Spincemaille K, Gorus F, Gerlo E. Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters.Clin Chim Acta 2007;386:63–68.
3. Newman JD, Ramsden CA, Balazs NDH. Monitoring neonatal hypoglycemia with the Accu-chek Advantage II glucose meter: The cautionary tale of galactosemia.Clin Chem 2002;48:2071.
4. Apperloo JJ, Vader HL. A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses.Clin Chem Lab Med 2005;43:314–318.
5. Mehmet S, Quan G, Thomas S, et al. Important causes of hypoglycemia in patients with diabetes on peritoneal dialysis.Diabet Med 2001;18:679–682.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献